Serum Soluble Interleukin-2 Receptor, Interleukin-6 and Tumor Necrosis Factor Alpha As Markers of Celiac Disease Activity

Overview

Journal Indian J Pediatr

Specialty Pediatrics

Date 2012 Jul 7

PMID 22766904

Citations 10

Authors

Akshay Kapoor

A K Patwari

Praveen Kumar

Anju Jain

Shashi Narayan

Affiliations

Soon will be listed here.

Abstract

Objectives: To evaluate the markers of lymphocyte activation (sIL-2R, IL-6 and TNF α) in the peripheral blood of newly diagnosed patients with celiac disease (CD) and patients with CD on Gluten free diet (GFD) for at least 2 y. The markers were correlated with conventional serological tests Anti-tissue transglutaminase (Anti-TTG) used for diagnosis and follow up of the disease; wherever possible.

Methods: Thirty newly diagnosed cases of CD (on the basis of histopathology and serology) not on GFD were enrolled as Group 1 of the study. Thirty age and sex matched controls from the Pediatric Surgery OPD formed Group 2. Thirty cases of CD on GFD for at least 2 y (Group 3) were also enrolled in the study. Upper G.I. endoscopy was performed in all Group 1 patients and cytokine levels assayed by ELISA on serum obtained from all patients in Groups 1, 2, 3.

Results: Mean sIL-2R level in Group 1(1498.1+/-1234.31 pg/ml) and Group 3 (488.78+/-396.18 pg/ml) were significantly higher than the controls (336.27+/-218.67 pg/ml p < 0.05). Among the patients with CD, mean serum levels in Group 1 were higher than in Group 3 (p < 0.05). sIL-2R levels showed good correlation with tTg levels in Group 1 patients (p < 0.000, r = 0.69). Mean IL-6 levels in Group 1 were significantly higher (28.43+/-28.32 pg/ml) than Group 2(15.03+/-7.72 pg/ml p < 0.05) and Group 3(11.26+/-5.13 pg/ml p < 0.05). IL-6 levels were comparable between Groups 2 and 3 (p > 0.05).IL-6 levels showed good correlation with tTg levels in Group 1(p < 0.008, r = 0.471). Mean TNFα levels in Group 1(179.66+/-102.93 pg/ml), Group 2 (153.16+/-27.02 pg/ml) and Group 3 (166.67+/-28.95 pg/ml) were comparable (p > 0.05). TNFα levels showed poor correlation with tTg levels in Group 1 patients (p > 0.604, r = -0.099).

Conclusions: sIL-2R and IL-6 levels have a good correlation with CD activity and can be used as reliable markers for detecting minimal transgression from GFD.

Citing Articles

Ocular manifestations in celiac disease: an overview.

Fousekis F, Katsanos A, Katsanos K, Christodoulou D Int Ophthalmol. 2020; 40(4):1049-1054.

PMID: 31916055 DOI: 10.1007/s10792-019-01254-x.

Celiac Disease in Children, Particularly with Accompanying Type 1 Diabetes, Is Characterized by Substantial Changes in the Blood Cytokine Balance, Which May Reflect Inflammatory Processes in the Small Intestinal Mucosa.

Vorobjova T, Tagoma A, Oras A, Alnek K, Kisand K, Talja I J Immunol Res. 2019; 2019:6179243.

PMID: 31214623 PMC: 6535873. DOI: 10.1155/2019/6179243.

The relationship between 174 G/C and -572 G/C of IL-6 gene polymorphisms and susceptibility of celiac disease in the Iranian population.

Barartabar Z, Nikzamir A, Sirati-Sabet M, Aghamohammadi E, Chaleshi V, Rostami Nejad M Prz Gastroenterol. 2018; 13(4):293-298.

PMID: 30581503 PMC: 6300853. DOI: 10.5114/pg.2018.79808.

Intestinal parameters of oxidative imbalance in celiac adults with extraintestinal manifestations.

Piatek-Guziewicz A, Ptak-Belowska A, Przybylska-Felus M, Pasko P, Zagrodzki P, Brzozowski T World J Gastroenterol. 2017; 23(44):7849-7862.

PMID: 29209126 PMC: 5703914. DOI: 10.3748/wjg.v23.i44.7849.

Markers of inflammation and cardiovascular disease in recently diagnosed celiac disease patients.

Tetzlaff W, Merono T, Menafra M, Martin M, Botta E, Matoso M World J Cardiol. 2017; 9(5):448-456.

PMID: 28603593 PMC: 5442414. DOI: 10.4330/wjc.v9.i5.448.

References

Lundin K, Scott H, Hansen T, Paulsen G, Halstensen T, Fausa O . Gliadin-specific, HLA-DQ(alpha 1*0501,beta 1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients. J Exp Med. 1993; 178(1):187-96. PMC: 2191064. DOI: 10.1084/jem.178.1.187. View

Nilsen E, Lundin K, Krajci P, Scott H, Sollid L, Brandtzaeg P . Gluten specific, HLA-DQ restricted T cells from coeliac mucosa produce cytokines with Th1 or Th0 profile dominated by interferon gamma. Gut. 1995; 37(6):766-76. PMC: 1382937. DOI: 10.1136/gut.37.6.766. View

Crabtree J, Heatley R, Juby L, Howdle P, Losowsky M . Serum interleukin-2-receptor in coeliac disease: response to treatment and gluten challenge. Clin Exp Immunol. 1989; 77(3):345-8. PMC: 1542053. View

Khoshoo V, Bhan M, Puri S, Jain R, Jayashree S, Bhatnagar S . Serum anti-gliadin antibody profile in childhood protracted diarrhoea due to coeliac disease and other causes in a developing country. Scand J Gastroenterol. 1989; 24(10):1212-6. DOI: 10.3109/00365528909090789. View

Pober J . Warner-Lambert/Parke-Davis award lecture. Cytokine-mediated activation of vascular endothelium. Physiology and pathology. Am J Pathol. 1988; 133(3):426-33. PMC: 1880803. View

Penttila I, Gibson C, Forrest B, Cummins A, LaBrooy J . Lymphocyte activation as measured by interleukin-2 receptor expression to gluten fraction 111 in coeliac disease. Immunol Cell Biol. 1990; 68 ( Pt 3):155-60. DOI: 10.1038/icb.1990.22. View

Jelinkova L, Tuckova L, Sanchez D, Krupickova S, Pozler O, Nevoral J . Increased levels of circulating ICAM-1, E-selectin, and IL-2 receptors in celiac disease. Dig Dis Sci. 2000; 45(2):398-402. DOI: 10.1023/a:1005489316037. View

Blanco A, Garrote J, Arranz E, Alonso M, Clavo C . Increased serum IL-2R levels in coeliac disease are related to CD4 but not CD8 antigens. J Pediatr Gastroenterol Nutr. 1992; 15(4):413-7. DOI: 10.1097/00005176-199211000-00008. View

Sturgess R, Hooper L, Spencer J, Hung C, Nelufer J, Ciclitira P . Effects of interferon-gamma and tumour necrosis factor-alpha on epithelial HLA class-II expression on jejunal mucosal biopsy specimens cultured in vitro. Scand J Gastroenterol. 1992; 27(11):907-11. DOI: 10.3109/00365529209000161. View

10.

Hansson T, Dannaeus A, Klareskog L . Cytokine-producing cells in peripheral blood of children with coeliac disease secrete cytokines with a type 1 profile. Clin Exp Immunol. 1999; 116(2):246-50. PMC: 1905277. DOI: 10.1046/j.1365-2249.1999.00882.x. View

11.

Ming W, Bersani L, Mantovani A . Tumor necrosis factor is chemotactic for monocytes and polymorphonuclear leukocytes. J Immunol. 1987; 138(5):1469-74. View

12.

Cummins A, Penttila I, LaBrooy J, ROBB T, Davidson G . Recovery of the small intestine in coeliac disease on a gluten-free diet: changes in intestinal permeability, small bowel morphology and T-cell activity. J Gastroenterol Hepatol. 1991; 6(1):53-7. DOI: 10.1111/j.1440-1746.1991.tb01145.x. View

13.

OKeeffe J, Mills K, Jackson J, Feighery C . T cell proliferation, MHC class II restriction and cytokine products of gliadin-stimulated peripheral blood mononuclear cells (PBMC). Clin Exp Immunol. 1999; 117(2):269-76. PMC: 1905335. DOI: 10.1046/j.1365-2249.1999.00973.x. View

14.

Fasano A, Berti I, Gerarduzzi T, Not T, Colletti R, Drago S . Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med. 2003; 163(3):286-92. DOI: 10.1001/archinte.163.3.286. View

15.

Marsh M . Immunocytes, enterocytes and the lamina propria: an immunopathological framework of coeliac disease. J R Coll Physicians Lond. 1983; 17(4):205-12. PMC: 5370856. View

16.

Fornari M, Pedreira S, Niveloni S, Gonzalez D, Diez R, Vazquez H . Pre- and post-treatment serum levels of cytokines IL-1beta, IL-6, and IL-1 receptor antagonist in celiac disease. Are they related to the associated osteopenia?. Am J Gastroenterol. 1998; 93(3):413-8. DOI: 10.1111/j.1572-0241.1998.00413.x. View

17.

Przemioslo R, Kontakou M, Nobili V, Ciclitira P . Raised pro-inflammatory cytokines interleukin 6 and tumour necrosis factor alpha in coeliac disease mucosa detected by immunohistochemistry. Gut. 1994; 35(10):1398-403. PMC: 1375013. DOI: 10.1136/gut.35.10.1398. View

18.

Gjertsen H, Sollid L, Ek J, Thorsby E, Lundin K . T cells from the peripheral blood of coeliac disease patients recognize gluten antigens when presented by HLA-DR, -DQ, or -DP molecules. Scand J Immunol. 1994; 39(6):567-74. DOI: 10.1111/j.1365-3083.1994.tb03414.x. View

19.

Romaldini C, Barbieri D, Okay T, Raiz Jr R, Cancado E . Serum soluble interleukin-2 receptor, interleukin-6, and tumor necrosis factor-alpha levels in children with celiac disease: response to treatment. J Pediatr Gastroenterol Nutr. 2002; 35(4):513-7. DOI: 10.1097/00005176-200210000-00010. View

20.

Marsh M . Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity ('celiac sprue'). Gastroenterology. 1992; 102(1):330-54. View